NFKB1 and infection: While both compounds had improved cellular outcomes in relation to the solvent control, the antioxidant therapeutic had the most significant recovery, indicating that mitochondrially derived ROS contributes more significantly to these infection phenotypes than the NF-κB inflammatory response.